Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
Clinical trial NCT05886088 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05886088
- Sponsor
- EMS
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-05-01
- Enrollment
- 597
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.